Cerebrolysin or Cerebrolysin‐like agents vs placebo
Non‐death attrition · people with acute ischemic stroke
It is very uncertain whether cerebrolysin or Cerebrolysin‐like agents changes non‐death attrition compared with placebo (very low certainty).
1 finding from 1 review
- RR 0.72 [0.38, 1.39]6 studies · 1689 participantsVery low